AMNIS IMAGE STREAM MKII FLOW CYTOMETER INTERMEDIATE SERVICE AGREEMENT

Active

Contract Opportunity

This is a Notice of Intent, NOT a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Cytek Biosciences, Inc, 47215 Lakeview Blvd., Fremont, CA 94538 to procure a renewal service agreement for the Cytek Amnis ImageStream MK II Flow Cytometer Intermediate service agreement, serial number ISX503.

The Immunopathogenesis Section (IS) within the Nationals Institute of Allergy and Infectious Diseases (NIAID) Conducts basic research on the molecular and cellular mechanisms of the immunopathogenesis of HIV infection; studies the cellular and humoral immune responses against HIV infection focusing on the fine specificities of recognition of HIV epitopes by cytotoxic T cells; conducts studies on the cellular and molecular mechanisms of neuropathogenesis of HIV infection; studies the epidemiology and immunopathogenesis of HIV infection in selected population groups; studies the immunopathogenesis of Chlamydia; studies the cellular molecular mechanisms of the activation, proliferation, and differentiation of human B cells; studies the mechanism of expression of B cell specific activation genes; studies the molecular biological control of the T cell activation process and investigates the role of newly recognized T cell genes in the activation process; and studies the immunopathogenic mechanisms of a number of immune mediated diseases.

The Laboratory of Immunoregulation (LIR) currently owns one Amnis Imagestream MKII instrument located in BSL-II/III lab 6A30 of Building 10. It is used for visualizing cells isolated from participants in multiple clinical research protocols. In order to maintain the integrity of on-going research it is imperative that this instrument be maintained in fully operational status. Cytek is the sole provider of Amnis lmageStream Mk II instrument, service, and spare parts. Therefore, a renewal service agreement is required for the following:

Cytek Amnis ImageStream MK II Flow Cytometer Intermediate service agreement,

S/N: ISX503.

The Contractor MUST provide the following services:

• Limited on-site service coverage (OEM parts, labor and travel are included for first service


• visit only, excluding preventative Maintenance)


• One annual preventative maintenance calibration


• Trained and authorized OEM service technicians


• Technical support services


• Priority scheduling of service requests


• Firmware and software updates

Priority scheduling and onsite response for all repairs during the period of performance.

Priority is defined as giving priority scheduling equal to a direct contract and guaranteeing

the equivalent manufacturer’s priority onsite response. If you are a third-party service

provider, the priority scheduling and/or response time, must be listed on a capabilities

statement, as well as documentation of OEM trained technicians is required. If you are a third-party service provider, the priority scheduling and/or response time, must be listed on a capabilities statement/quote , as well as documentation of OEM trained technicians is required.

*All service providers must provide proof from Cytek Biosciences, Inc., that they are an authorized service provider for the equipment.* While this pre-solicitation does not constitute a solicitation, interested vendors may identify their interest and capability to satisfy this requirement. The Government understands that Cytek Biosciences, Inc. is the sole provider of the required service currently being utilized by NIAID per continuity protocols and compatibility requirements. However, vendors that believe they can provide the capability required to fully meet the Government's requirement may submit a capabilities statement, including past performance, in writing to the identified point of contact prior to the closing date and time of this notice. Such documentation shall be evaluated solely for the purpose of determining whether or not to conduct this procurement on a competitive basis. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. Interested parties may identify their interest and capability to respond to the requirement on NOI-NIAID-25-2260924.

Period of Performance: 05/20/2025 – 05/19/2026

Place of Performance: NIH, NIAID, 10 Center Drive, Bldg 10, Bethesda, MD 20892, United States. FOB: Destination

The statutory authority for this sole source requirement is 41 U.S.C. 1901 (a) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide this service may submit a capability statement along with a copy of agreement with manufacturer to service Cytek Biosciences equipment to be considered by 10:00 am EST, May 16, 2025. All Capability Statements must be submitted via the NIAID electronic SIMPLIFIED ACQUISITION SUBMISSION SYSTEM (eSASS) website at https://esass.nih.gov. All vendors must register in the eSASS system to submit their documentation. Instructions on how to register /submit documents are included on the website. Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f). All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.

Attachments/Links